SecBot SecBot
SC 13G/A ·Filed Nov 16, 2026

YARW

Yarrow Bioscience, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed1d 2h ago SEC0001274173-26-000261
Passive stake amendment
Actionable Insight • Neutral

This passive 3% stake from a major asset manager is routine and adds to the institutional accumulation pattern seen in recent 13G filings. Monitor for any future conversion to a 13D filing, which would signal activist intent, but no such indication exists here.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Janus Henderson Group Ltd. filed an amended Schedule 13G disclosing a 3.0% passive beneficial ownership stake in Yarrow Bioscience as of September 30, 2026, representing 283,341 shares. This is a new passive disclosure from a large asset manager, adding to a series of recent 13G filings by other institutions following Yarrow's September 2026 equity offering. The stake is below 5% and carries no activist intent.

Key Financial Metrics

Stake
3%
Investor
Janus Henderson Group Ltd.
Investor Type
mutual fund

Key Facts

  • Janus Henderson Group Ltd. disclosed a 3.0% beneficial ownership stake in Yarrow Bioscience as of September 30, 2026
  • The stake consists of 283,341 shares of common stock
  • The filing is an amendment to Schedule 13G, indicating passive investment intent
  • Janus Henderson is the ultimate parent of multiple SEC-registered investment advisers and foreign equivalents
  • No single managed portfolio within Janus Henderson owns more than 5% of Yarrow Bioscience's common stock

Financial Impact

3.0% stake valued at approximately $5.5M based on $183M market cap

ownership structure

Risk Factors

  • No material risks identified from this passive stake filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001274173-26-000261
Document: Item_7.txt0001274173-26-000261
Document: 0001274173-26-000261-index-headers.html0001274173-26-000261
Document: 0001274173-26-000261-index.html0001274173-26-000261
Document: 0001274173-26-000261.txt0001274173-26-000261

Track record

13 reports on YARW

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 17, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $14.20 Now $14.27 +0.49% settles Dec 16
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
  4. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
  5. Nov 16, 20261d ago SC 13G/A Neutral 3/10 Viewing Entry $15.44 Now $14.27 −7.58% settles Dec 15
  6. Nov 16, 20261d ago SC 13G Neutral 3/10 Entry $18.20 Now $14.27 −21.59% settles Dec 15
  7. Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
  8. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $17.35 Now $14.27 −17.75% settles Dec 15
  9. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
  10. Nov 12, 20265d ago 8-K Neutral 4/10 Entry $19.63 Now $14.27 −27.31% settles Dec 11
Showing 10 of 13

US Market Status

Market Open · Closes in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026